Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke
Cardiovascular Research · 14.08.2026 · 122 (11) · 1443-1454
DOI: 10.1093/cvr/cvag116 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cardiovascular Research, online erschienen am 02.06.2026. Verfasst von Tian Lan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, University Utrecht, Heidelberglaan 100, 3584 CX U…. Hauptthemen laut MEDLINE: Amaurosis Fugax, Ischemic Attack, Transient, Plaque, Atherosclerotic, Carotid Stenosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Scholarship Council (CSC), Dutch Heart Foundation, Leducq Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Aims
In patients with atherosclerotic internal carotid artery stenosis, the risk of subsequent ischaemic stroke is higher in those presenting with a cerebral transient ischaemic attack (TIA) than in those with amaurosis fugax (AFX; transient monocular blindness). While AFX is associated with more stable histological characteristics, the underlying molecular mechanisms remain unclear. We hypothesized that biological processes and gene expression profiles in carotid plaques of patients with AFX differ from those with cerebral TIA and stroke. Methods and results We analysed carotid plaques from 2508 patients undergoing endarterectomy between 2002 and 2022. Bulk RNA sequencing (RNA-seq) was performed on 1088 plaques (136 asymptomatic, 179 AFX, 481 TIA, 292 stroke). Single-cell RNA-seq from 46 previously profiled plaques was used to identify cell-specific transcriptomic signatures. Mass spectrometry-based proteomics (n = 189) and targeted plasma proteomics (n = 1291) were used to validate the molecular differences. AFX plaques showed fewer lipid-rich cores than those from cerebral TIA [odds ratio (95% CI): 1.41 (1.03–1.94)] or stroke [1.42 (1.01–1.99)]. RNA-seq identified 408 differentially expressed genes (DEGs) between AFX and TIA and 463 between AFX and stroke (FDR < 0.1), while AFX and asymptomatic plaques showed only 10 DEGs. AFX plaques were enriched for vascular smooth muscle cell signatures and extracellular matrix remodelling, while cerebral TIA and stroke plaques exhibited macrophage-driven inflammatory molecular signatures. These transcriptomic differences were confirmed by plaque proteomic analyses. In parallel, circulating proteomic profiling revealed higher levels of inflammatory and thrombo-inflammatory markers in cerebral TIA and stroke compared with AFX.
Conclusion
AFX plaques exhibit stable, SMC-dominant molecular signatures that differ markedly from the macrophage-driven inflammatory profiles of cerebral TIA and stroke plaques. These findings support AFX as a biologically distinct entity with potential implications for risk stratification and personalized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, University Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
- Central Diagnostic Laboratory, Division Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, University Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
- Department of Genome Sciences, University of Virginia, 1335 Lee Street, West Complex, Charlottesville, VA 22903, USA.
- Department of Vascular Surgery, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
- Board of Directors, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, The Netherlands.
ORCID-Profile: Ynte M Ruigrok, Joost A van Herwaarden, Martin Dichgans, Hester M den Ruijter, Gerard Pasterkamp, Michal Mokry
Förderung
- Chinese Scholarship Council (CSC)
- Dutch Heart Foundation
- Leducq Foundation
- EU H2020
- EU HORIZON NextGen
- EU HORIZON MIRACLE
- Chan Zuckerberg Initiative
- Health∼Holland
Zitieren
APA
Lan, T., van der Zalm, F. B. H., Palm, K. C. A., Zhu, Y., Diez Benavente, E., van der Laan, S. W., de Kleijn, D. P. V., Ruigrok, Y. M., van Herwaarden, J. A., de Borst, G. J., Bart van der Worp, H., Dichgans, M., den Ruijter, H. M., Pasterkamp, G., & Mokry, M. (2026). Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke. Cardiovascular Research, 122(11), 1443-1454. https://doi.org/10.1093/cvr/cvag116
Vancouver
Lan T, van der Zalm FBH, Palm KCA, Zhu Y, Diez Benavente E, van der Laan SW, et al. Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke. Cardiovascular Research. 2026;122(11):1443-1454. doi:10.1093/cvr/cvag116
BibTeX
@article{Lan2026,
author = {Lan, Tian and van der Zalm, Floor B H and Palm, Kaylin C A and Zhu, Yayuan and Diez Benavente, Ernest and van der Laan, Sander W and de Kleijn, Dominique P V and Ruigrok, Ynte M and van Herwaarden, Joost A and de Borst, Gert J and Bart van der Worp, Hendrik and Dichgans, Martin and den Ruijter, Hester M and Pasterkamp, Gerard and Mokry, Michal},
title = {Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {11},
pages = {1443--1454},
doi = {10.1093/cvr/cvag116}
}
EUVIMED